Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2006

View Archived Issues

YM-201627 presented as a new agent for solid tumors

Preclinical experiments support use of desvenlafaxine for menopause symptoms

Increlex stability, structural features detailed

GTx reports on novel nonsteroidal selective androgen receptor modulators

Cardioprotective effects of a new exendin-4 analogue

Iplex shows promise in severe insulin resistance syndromes

Bremelanotide affects desire and arousal in female sexual arousal disorder patients

S-2367 shows efficacy in maintaining and continuing weight loss in obese subjects

Japanese submission for minodronic acid hydrate in osteoporosis

Pivotal study begins for HuMax-CD20 in NHL

Takeda licenses rights to Galaxy's anti-HGF antibody

Grant for study of alagebrium effects on renal function in diabetes patients

Antigenics and GSK expand license and supply agreements for QS-21 adjuvant

Approvable letter for Cellegesic

Pivotal study of Mozobil completes enrollment

PRX-08066 relaxes pulmonary arteries without affecting systemic blood pressure in rodents

Astemizole shows antimalarial potential in preclinical studies

JNJ-1250132: A unique progesterone receptor modulator

Hemopure submitted for U.K. approval

Avandamet approved for initial treatment of type 2 diabetes

FDA approves Emend for prevention of postoperative nausea and vomiting

Recent patents report novel vanilloid VR1 receptor antagonists

Recent patents disclose novel agents for HCV infection

Schizophrenia, depression, etc. targets of newly patented compounds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...